gallibacterium anatis cytolytic rtx toxin. The present invention relates to the field of animal health and in particular to the causative agent of a new bacterial bird disease caused by gallibacteruim spp, including gallibacterium anatis, gallibacterium genomospecies 1 and gallibacterium genomospecies 2. The invention provides a novel rtx toxin from the so-called gallibacterium species, the new toxin being called gtxa (gallibacterium toxin). furthermore, the invention provides the gtxa amino acid and nucleotide sequences, a vaccine comprising inactivated toxoid or toxoid fragments, as well as bird immunization methods to prevent said disease, and methods for diagnosing a gallibacterium anatis infection in birds. .
展开▼